Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Thyroid Cancer and Iodine Deficiency Status: A 10-Year Review at a Single Cancer Center in Tanzania.

Sakafu LL, Mselle TF, Mwaiselage JD, Maunda KK, Eddin BS, Zafereo ME.

OTO Open. 2018 May 22;2(2):2473974X18777238. doi: 10.1177/2473974X18777238. eCollection 2018 Apr-Jun.

2.

ASO Author Reflections: Strap Muscle Invasion Does Not Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer.

Amit M, Boonsripitayanon M, Zafereo ME.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):892-893. doi: 10.1245/s10434-018-6816-8. Epub 2018 Sep 27. No abstract available.

PMID:
30264249
3.

Decision making for the central compartment in differentiated thyroid cancer.

Gon├žalves Filho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Hefetz AK, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz A, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP.

Eur J Surg Oncol. 2018 Nov;44(11):1671-1678. doi: 10.1016/j.ejso.2018.08.005. Epub 2018 Aug 13. Review.

PMID:
30145001
4.

Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.

Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME.

Thyroid. 2018 Oct;28(10):1301-1310. doi: 10.1089/thy.2017.0572.

PMID:
30141373
5.

Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?

Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME.

Ann Surg Oncol. 2018 Oct;25(11):3380-3388. doi: 10.1245/s10434-018-6563-x. Epub 2018 Jul 18.

PMID:
30022274
6.

Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.

Tam S, Amit M, Boonsripitayanon M, Busaidy NL, Cabanillas ME, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis EM, Zafereo ME.

Thyroid. 2018 Aug;28(8):982-990. doi: 10.1089/thy.2017.0513. Epub 2018 Jul 27.

PMID:
29936892
7.

The Small World of Global Otolaryngology.

Saunders JE, Cordes SR, Zafereo ME.

Otolaryngol Clin North Am. 2018 Jun;51(3):xix-xx. doi: 10.1016/j.otc.2018.02.002. No abstract available.

PMID:
29773126
8.

Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.

Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI.

Oral Oncol. 2018 Apr;79:1-8. doi: 10.1016/j.oraloncology.2018.01.025. Epub 2018 Feb 10.

9.

Thyroid Disease Around the World.

Maniakas A, Davies L, Zafereo ME.

Otolaryngol Clin North Am. 2018 Jun;51(3):631-642. doi: 10.1016/j.otc.2018.01.014. Epub 2018 Mar 13. Review.

PMID:
29548512
10.

Imaging of Anaplastic Thyroid Carcinoma.

Ahmed S, Ghazarian MP, Cabanillas ME, Zafereo ME, Williams MD, Vu T, Schomer DF, Debnam JM.

AJNR Am J Neuroradiol. 2018 Mar;39(3):547-551. doi: 10.3174/ajnr.A5487. Epub 2017 Dec 14.

11.

Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.

Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME.

JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):108-114. doi: 10.1001/jamaoto.2017.2416. Erratum in: JAMA Otolaryngol Head Neck Surg. 2019 May 1;145(5):484.

12.

Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer.

Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Gunn GB, Lai SY, Gross ND, Sturgis EM, Zafereo ME.

JAMA Otolaryngol Head Neck Surg. 2017 Dec 1;143(12):1244-1251. doi: 10.1001/jamaoto.2017.2077. No abstract available.

13.

Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer.

Pena I, Clayman GL, Grubbs EG, Bergeron JM Jr, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME.

Head Neck. 2018 Jan;40(1):79-85. doi: 10.1002/hed.24969. Epub 2017 Oct 16.

PMID:
29044788
14.

Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer.

Chinn SB, Zafereo ME, Waguespack SG, Edeiken BS, Roberts DB, Clayman GL.

Thyroid. 2017 Oct;27(10):1291-1299. doi: 10.1089/thy.2017.0203. Epub 2017 Sep 14.

PMID:
28806882
15.

Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis.

Pollard C 3rd, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J.

Head Neck. 2017 Oct;39(10):2079-2087. doi: 10.1002/hed.24872. Epub 2017 Jul 25.

PMID:
28741749
16.

Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx.

Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD.

Head Neck. 2017 Aug;39(8):1609-1620. doi: 10.1002/hed.24804. Epub 2017 May 2.

17.

Complications, hospital length of stay, and readmission after total laryngectomy.

Goepfert RP, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC, Lewis CM, Weber RS, Gross ND.

Cancer. 2017 May 15;123(10):1760-1767. doi: 10.1002/cncr.30483. Epub 2016 Dec 27.

18.

Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy.

Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN Jr, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS.

Head Neck. 2017 Apr;39(4):633-638. doi: 10.1002/hed.24666. Epub 2016 Dec 22.

PMID:
28006086
19.

Sentinel lymph node biopsy for ocular adnexal melanoma.

Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, Thakar S, Thuro B, Prieto VG, Ross MI, Esmaeli B.

Acta Ophthalmol. 2017 Jun;95(4):e323-e328. doi: 10.1111/aos.13252. Epub 2016 Oct 24.

20.

Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture.

Gitomer SA, Hutcheson KA, Christianson BL, Samuelson MB, Barringer DA, Roberts DB, Hessel AC, Weber RS, Lewin JS, Zafereo ME.

Head Neck. 2016 Dec;38(12):1765-1771. doi: 10.1002/hed.24529. Epub 2016 Jul 9.

21.

Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.

Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN Jr, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1117-31. doi: 10.1016/j.ijrobp.2016.03.015. Epub 2016 Mar 19.

PMID:
27354127
22.

Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.

Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN Jr, Frank SJ.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):30-41. doi: 10.1016/j.ijrobp.2016.03.053. Epub 2016 Apr 13.

PMID:
27325480
23.

Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus.

Zafereo ME, Xu L, Dahlstrom KR, Viamonte CA, El-Naggar AK, Wei Q, Li G, Sturgis EM.

Oral Oncol. 2016 May;56:47-53. doi: 10.1016/j.oraloncology.2016.03.003. Epub 2016 Mar 21.

24.

Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.

Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME.

Head Neck. 2016 Apr;38 Suppl 1:E1962-8. doi: 10.1002/hed.24355. Epub 2016 Feb 16.

25.

Sinonasal melanoma arising from conjunctival primary acquired melanosis.

Shehata M, Gombos D, Bishop J, Zafereo ME.

BMJ Case Rep. 2015 Feb 18;2015. pii: bcr2014208522. doi: 10.1136/bcr-2014-208522.

26.

Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.

Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB.

Oral Oncol. 2015 Feb;51(2):195-201. doi: 10.1016/j.oraloncology.2014.11.001. Epub 2014 Nov 28.

27.

TNF-╬▒ promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.

Zhang C, Sturgis EM, Zheng H, Zafereo ME, Wei Q, Li G.

Int J Cancer. 2014 Oct 1;135(7):1615-24. doi: 10.1002/ijc.28793. Epub 2014 Feb 27.

28.

Evaluation and staging of squamous cell carcinoma of the oral cavity and oropharynx: limitations despite technological breakthroughs.

Zafereo ME.

Otolaryngol Clin North Am. 2013 Aug;46(4):599-613. doi: 10.1016/j.otc.2013.04.011. Epub 2013 Jun 21. Review.

PMID:
23910472
29.

Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.

Gan SJ, Dahlstrom KR, Peck BW, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM.

Cancer. 2013 Jul 15;119(14):2593-601. doi: 10.1002/cncr.28107. Epub 2013 Apr 19.

30.

Section for residents and fellows-in-training survey results.

Rosenberg TL, Kelley K, Dowdall JR, Replogle WH, Liu JC, Raol NP, Zafereo ME.

Otolaryngol Head Neck Surg. 2013 Apr;148(4):582-8. doi: 10.1177/0194599813477353. Epub 2013 Feb 8.

PMID:
23396591
31.

Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.

Peck BW, Dahlstrom KR, Gan SJ, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM.

Head Neck. 2013 Jun;35(6):794-9. doi: 10.1002/hed.23033. Epub 2012 Jun 19.

32.

Neighborhood deprivation and clinical outcomes among head and neck cancer patients.

Reitzel LR, Nguyen N, Zafereo ME, Li G, Wei Q, Sturgis EM.

Health Place. 2012 Jul;18(4):861-8. doi: 10.1016/j.healthplace.2012.03.005. Epub 2012 Mar 14.

33.

Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans.

Xu L, Mugartegui L, Li G, Sarlis NJ, Wei Q, Zafereo ME, Sturgis EM.

Mol Carcinog. 2012 Oct;51 Suppl 1:E158-67. doi: 10.1002/mc.21900. Epub 2012 Mar 13.

34.

Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.

Zhang Y, Sturgis EM, Huang Z, Zafereo ME, Wei Q, Li G.

Cancer. 2012 Jan 15;118(2):485-92. doi: 10.1002/cncr.26222. Epub 2011 Jun 29.

35.

p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Zhang Y, Sturgis EM, Zafereo ME, Wei Q, Li G.

Cancer. 2011 Mar 15;117(6):1227-35. doi: 10.1002/cncr.25605. Epub 2010 Nov 8.

36.

FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.

Lei D, Sturgis EM, Wang LE, Liu Z, Zafereo ME, Wei Q, Li G.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1484-91. doi: 10.1158/1055-9965.EPI-10-0030. Epub 2010 May 25.

37.

Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.

Li F, Sturgis EM, Chen X, Zafereo ME, Wei Q, Li G.

Cancer. 2010 May 15;116(10):2350-9. doi: 10.1002/cncr.25072.

38.

Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Lei D, Sturgis EM, Liu Z, Zafereo ME, Wei Q, Li G.

Carcinogenesis. 2010 Feb;31(2):222-7. doi: 10.1093/carcin/bgp279. Epub 2009 Dec 2.

39.

Complications and functional outcomes following complex oropharyngeal reconstruction.

Zafereo ME, Weber RS, Lewin JS, Roberts DB, Hanasono MM.

Head Neck. 2010 Aug;32(8):1003-11. doi: 10.1002/hed.21290.

PMID:
19953614
40.

The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx.

Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB, Weber RS.

Cancer. 2009 Dec 15;115(24):5723-33. doi: 10.1002/cncr.24595.

41.

Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care.

Chen LM, Li G, Reitzel LR, Pytynia KB, Zafereo ME, Wei Q, Sturgis EM.

Cancer Prev Res (Phila). 2009 Sep;2(9):782-91. doi: 10.1158/1940-6207.CAPR-09-0154. Epub 2009 Sep 8.

42.

p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.

Li F, Sturgis EM, Zafereo ME, Liu Z, Wang LE, Wei Q, Li G.

Int J Cancer. 2009 Dec 1;125(11):2660-5. doi: 10.1002/ijc.24570.

43.

Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck.

Zafereo ME, Sturgis EM, Aleem S, Chaung K, Wei Q, Li G.

Cancer Prev Res (Phila). 2009 May;2(5):432-9. doi: 10.1158/1940-6207.CAPR-08-0222. Epub 2009 Apr 28.

44.

Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Zafereo ME, Sturgis EM, Liu Z, Wang LE, Wei Q, Li G.

Carcinogenesis. 2009 Jun;30(6):997-1002. doi: 10.1093/carcin/bgp096. Epub 2009 Apr 15.

45.

Supraglottoplasty for laryngomalacia with obstructive sleep apnea.

Zafereo ME, Taylor RJ, Pereira KD.

Laryngoscope. 2008 Oct;118(10):1873-7. doi: 10.1097/MLG.0b013e31817e7441.

PMID:
18641529
46.

Chronic retropharyngeal abscess presenting as obstructive sleep apnea.

Zafereo ME Jr, Pereira KD.

Pediatr Emerg Care. 2008 Jun;24(6):382-4. doi: 10.1097/PEC.0b013e318177a6d9.

PMID:
18562883
47.

Esthesioneuroblastoma: 25-year experience at a single institution.

Zafereo ME, Fakhri S, Prayson R, Batra PS, Lee J, Lanza DC, Citardi MJ.

Otolaryngol Head Neck Surg. 2008 Apr;138(4):452-8. doi: 10.1016/j.otohns.2007.12.038.

PMID:
18359353
48.

Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study.

Dahlstrom KR, Little JA, Zafereo ME, Lung M, Wei Q, Sturgis EM.

Head Neck. 2008 Jan;30(1):75-84.

PMID:
17694557
49.

Effect of initial treatment on disease outcome for patients with submandibular gland carcinoma.

Kaszuba SM, Zafereo ME, Rosenthal DI, El-Naggar AK, Weber RS.

Arch Otolaryngol Head Neck Surg. 2007 Jun;133(6):546-50.

PMID:
17576904

Supplemental Content

Loading ...
Support Center